We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-20.88%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$377M
AUM Growth
-$204M
Cap. Flow
-$90.4M
Cap. Flow %
-23.98%
Top 10 Hldgs %
43.04%
Holding
146
New
4
Increased
24
Reduced
60
Closed
45

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$4.89M
2
GVA icon
Granite Construction
GVA
+$3.96M
3
TSM icon
TSMC
TSM
+$3.4M
4
VZ icon
Verizon
VZ
+$3.35M
5
AVGO icon
Broadcom
AVGO
+$3.21M

Sector Composition

Rank Sector Weight
1 Healthcare 35.22%
2 Technology 22.17%
3 Industrials 21.7%
4 Utilities 6.56%
5 Communication Services 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
26
TE Connectivity
TEL
$62.6B
$4.79M 1.27%
76,000
-1,700
-2% -$145K
AGX icon
27
Argan
AGX
$8.37B
$4.61M 1.22%
133,275
-1,400
-1% -$58.1K
TSM icon
28
TSMC
TSM
$2.18T
$4.51M 1.2%
94,419
+62,100
+192% +$3.4M
ACM icon
29
Aecom
ACM
$9.75B
$4.24M 1.13%
142,150
-6,000
-4% -$257K
IDA icon
30
Idacorp
IDA
$8.2B
$3.96M 1.05%
45,109
-205
-0.5% -$21.1K
DGX icon
31
Quest Diagnostics
DGX
$26.3B
$3.75M 1%
46,736
-50
-0.1% -$5.18K
ALB icon
32
Albemarle
ALB
$15.5B
$3.71M 0.98%
65,800
-6,700
-9% -$513K
ELAN icon
33
Elanco Animal Health
ELAN
$11.1B
$3.48M 0.92%
155,200
-1,300
-0.8% -$35.6K
XOM icon
34
ExxonMobil
XOM
$634B
$3.4M 0.9%
89,402
-167,296
-65% -$9.24M
VZ icon
35
Verizon
VZ
$196B
$3.39M 0.9%
63,081
+58,613
+1,312% +$3.35M
FLS icon
36
Flowserve
FLS
$10.2B
$3.26M 0.87%
136,482
-95,825
-41% -$3.87M
LFCR icon
37
Lifecore Biomedical
LFCR
$190M
$2.98M 0.79%
343,352
-26,533
-7% -$276K
AZTA icon
38
Azenta
AZTA
$1.48B
$2.84M 0.75%
93,088
-800
-0.9% -$29.1K
AVGO icon
39
Broadcom
AVGO
$2.04T
$2.7M 0.72%
+114,000
New +$3.21M
EWA icon
40
iShares MSCI Australia ETF
EWA
$1.45B
$2.6M 0.69%
167,400
-17,100
-9% -$350K
EWC icon
41
iShares MSCI Canada ETF
EWC
$6.33B
$2.57M 0.68%
117,567
-8,666
-7% -$237K
ASTE icon
42
Astec Industries
ASTE
$1.02B
$2.35M 0.62%
67,200
-1,200
-2% -$47K
PEG icon
43
Public Service Enterprise Group
PEG
$37.7B
$2.34M 0.62%
52,075
-310
-0.6% -$16.7K
HZNP
44
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.28M 0.61%
77,052
-1,300
-2% -$44K
T icon
45
AT&T
T
$163B
$2.25M 0.6%
101,964
+88,061
+633% +$2.41M
XRX icon
46
Xerox
XRX
$425M
$2.21M 0.59%
116,762
-10,775
-8% -$342K
HPQ icon
47
HP
HPQ
$27.5B
$1.92M 0.51%
110,800
-1,100
-1% -$22.3K
TDC icon
48
Teradata
TDC
$2.55B
$1.92M 0.51%
93,701
+16,401
+21% +$378K
CCK icon
49
Crown Holdings
CCK
$13.1B
$1.9M 0.5%
32,670
PHG icon
50
Philips
PHG
$26.1B
$1.69M 0.45%
52,840
+47,682
+924% +$1.69M

Similar funds

John G. Ullman & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, John G. Ullman & Associates held 146 positions worth $377M, down 35% from $581M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

John G. Ullman & Associates withdrew a net $90.4M in Q1 2020, closing 45 positions and reducing 60 holdings. Its most notable exit was iShares MSCI Emerging Markets Min Vol Factor ETF, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Broadcom worth $2.7M.

  • John G. Ullman & Associates's largest Q1 2020 buy was Broadcom: 114,000 shares worth $2.7M.
  • John G. Ullman & Associates added most to GSK in Q1 2020, an estimated $4.89M increase.
  • John G. Ullman & Associates's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $9.24M.
  • John G. Ullman & Associates fully exited iShares MSCI Emerging Markets Min Vol Factor ETF in Q1 2020, selling an estimated $11.9M.
  • John G. Ullman & Associates's ten largest holdings make up 43% of its $377M portfolio in Q1 2020.
  • John G. Ullman & Associates opened 4 new positions and closed 45 in Q1 2020.
  • John G. Ullman & Associates's portfolio value fell 35% quarter-over-quarter to $377M.

Based on John G. Ullman & Associates's 13F filing for Q1 2020, filed 14 Apr 2020.